Try our beta test site
1 study found for:    10561020 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Condition: Neoplasms
Intervention: Drug: HeFi-1 Monoclonal Antibody

Study has passed its completion date and status has not been verified in more than two years.